Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hitoshi Shimano

Showing results (231-240 of 317) with videos related to

Pageof 32
Sort By:
The Journal of Allergy and Clinical Immunology|January 2, 2023
ELOVL6 deficiency aggravates allergic airway inflammation through the ceramide-S1P pathway in miceKazufumi Yoshida, Yuko Morishima, Satoshi Ano, et al.
Journal of Lipid Research|April 26, 2007
SREBP-1-independent regulation of lipogenic gene expression in adipocytesMotohiro Sekiya, Naoya Yahagi, Takashi Matsuzaka, et al.
Molecular Metabolism|June 20, 2026
Skeletal muscle-specific deficiency of Rab geranylgeranyl transferase beta subunit induces myopathy and exacerbates the symptoms caused by HMG-CoA reductase deficiency in miceYoshinori Osaki, Yuhei Mizunoe, Yoshimi Nakagawa, et al.
Journal of Atherosclerosis and Thrombosis|July 8, 2008
Proposed guidelines for hypertriglyceridemia in Japan with non-HDL cholesterol as the second targetHitoshi Shimano, Hidenori Arai, Mariko Harada-Shiba, et al.
Biochemical and Biophysical Research Communications|December 17, 2009
The liver-enriched transcription factor CREBH is nutritionally regulated and activated by fatty acids and PPARalphaHirosuke Danno, Kiyo-aki Ishii, Yoshimi Nakagawa, et al.
Diabetes|November 25, 2003
Hepatic Akt activation induces marked hypoglycemia, hepatomegaly, and hypertriglyceridemia with sterol regulatory element binding protein involvementHiraku Ono, Hitoshi Shimano, Hideki Katagiri, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 6, 2011
Macrophage Elovl6 deficiency ameliorates foam cell formation and reduces atherosclerosis in low-density lipoprotein receptor-deficient miceRyo Saito, Takashi Matsuzaka, Tadayoshi Karasawa, et al.
Diabetes|February 28, 2004
Insulin-independent induction of sterol regulatory element-binding protein-1c expression in the livers of streptozotocin-treated miceTakashi Matsuzaka, Hitoshi Shimano, Naoya Yahagi, et al.
The Journal of Biological Chemistry|September 14, 2011
Inhibition of ubiquitin ligase F-box and WD repeat domain-containing 7α (Fbw7α) causes hepatosteatosis through Krüppel-like factor 5 (KLF5)/peroxisome proliferator-activated receptor γ2 (PPARγ2) pathway but not SREBP-1c protein in miceShin Kumadaki, Tadayoshi Karasawa, Takashi Matsuzaka, et al.
Molecular Metabolism|July 17, 2024
Dietary medium-chain fatty acids reduce hepatic fat accumulation via activation of a CREBH-FGF21 axisYe Cao, Masaya Araki, Yoshimi Nakagawa, et al.
Pageof 32

Showing results (231-240 of 317) with videos related to

Sort By:
Pageof 32
The Journal of Allergy and Clinical Immunology|January 2, 2023
ELOVL6 deficiency aggravates allergic airway inflammation through the ceramide-S1P pathway in miceKazufumi Yoshida, Yuko Morishima, Satoshi Ano, et al.
Journal of Lipid Research|April 26, 2007
SREBP-1-independent regulation of lipogenic gene expression in adipocytesMotohiro Sekiya, Naoya Yahagi, Takashi Matsuzaka, et al.
Molecular Metabolism|June 20, 2026
Skeletal muscle-specific deficiency of Rab geranylgeranyl transferase beta subunit induces myopathy and exacerbates the symptoms caused by HMG-CoA reductase deficiency in miceYoshinori Osaki, Yuhei Mizunoe, Yoshimi Nakagawa, et al.
Journal of Atherosclerosis and Thrombosis|July 8, 2008
Proposed guidelines for hypertriglyceridemia in Japan with non-HDL cholesterol as the second targetHitoshi Shimano, Hidenori Arai, Mariko Harada-Shiba, et al.
Biochemical and Biophysical Research Communications|December 17, 2009
The liver-enriched transcription factor CREBH is nutritionally regulated and activated by fatty acids and PPARalphaHirosuke Danno, Kiyo-aki Ishii, Yoshimi Nakagawa, et al.
Diabetes|November 25, 2003
Hepatic Akt activation induces marked hypoglycemia, hepatomegaly, and hypertriglyceridemia with sterol regulatory element binding protein involvementHiraku Ono, Hitoshi Shimano, Hideki Katagiri, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 6, 2011
Macrophage Elovl6 deficiency ameliorates foam cell formation and reduces atherosclerosis in low-density lipoprotein receptor-deficient miceRyo Saito, Takashi Matsuzaka, Tadayoshi Karasawa, et al.
Diabetes|February 28, 2004
Insulin-independent induction of sterol regulatory element-binding protein-1c expression in the livers of streptozotocin-treated miceTakashi Matsuzaka, Hitoshi Shimano, Naoya Yahagi, et al.
The Journal of Biological Chemistry|September 14, 2011
Inhibition of ubiquitin ligase F-box and WD repeat domain-containing 7α (Fbw7α) causes hepatosteatosis through Krüppel-like factor 5 (KLF5)/peroxisome proliferator-activated receptor γ2 (PPARγ2) pathway but not SREBP-1c protein in miceShin Kumadaki, Tadayoshi Karasawa, Takashi Matsuzaka, et al.
Molecular Metabolism|July 17, 2024
Dietary medium-chain fatty acids reduce hepatic fat accumulation via activation of a CREBH-FGF21 axisYe Cao, Masaya Araki, Yoshimi Nakagawa, et al.
Pageof 32